$PHCI
Panamera Holdings Corp

2023 Q1 Form 10-Q Financial Statement

#000164033423000397 Filed on March 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q3 2022 Q1
Revenue $25.00K $25.00K $0.00
YoY Change
Cost Of Revenue $25.97K $38.21K $0.00
YoY Change
Gross Profit -$970.00 -$13.21K $0.00
YoY Change
Gross Profit Margin -3.88% -52.84%
Selling, General & Admin $10.46K $4.950K $6.240K
YoY Change 67.63% -92.95%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.46K -$9.000K $6.237K
YoY Change 67.72% -112.82% 33.16%
Operating Profit -$11.43K -$4.210K -$6.237K
YoY Change 83.28% 33.16%
Interest Expense $965.00 -$600.00 $389.00
YoY Change 148.07% 100.0% -73.3%
% of Operating Profit
Other Income/Expense, Net $965.00 -$389.00
YoY Change -348.07% -73.3%
Pretax Income -$12.40K -$4.810K -$6.626K
YoY Change 87.08% -93.18% 7.9%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$12.40K -$4.810K -$6.626K
YoY Change 87.08% -93.18% 7.9%
Net Earnings / Revenue -49.58% -19.24%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 $0.00 -$169.10
COMMON SHARES
Basic Shares Outstanding 33.21M shares 39.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q3 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.680K $3.090K $10.00
YoY Change 36700.0% 30800.0%
Cash & Equivalents $3.675K $3.087K $14.00
Short-Term Investments
Other Short-Term Assets $0.00 $60.00
YoY Change
Inventory
Prepaid Expenses $0.00 $55.00
Receivables $8.330K $8.330K
Other Receivables $0.00 $1.100K
Total Short-Term Assets $12.01K $12.57K $10.00
YoY Change 119980.0% 125620.0% -93.24%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $12.01K $12.57K $10.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $12.01K $12.57K $10.00
YoY Change 119980.0% 125620.0% -93.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.40K $17.03K $15.15K
YoY Change 47.82% 26.05% 51.5%
Accrued Expenses $8.100K $7.710K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $43.95K $33.95K $8.840K
YoY Change 397.17% 2008.7% -92.63%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $74.44K $60.19K $23.98K
YoY Change 210.39% 298.0% -82.81%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $74.44K $60.19K $23.98K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $74.44K $60.19K $23.98K
YoY Change 210.39% 298.0% -82.81%
SHAREHOLDERS EQUITY
Retained Earnings -$414.7K -$398.0K -$373.1K
YoY Change 11.13% 9.35% 30.05%
Common Stock $3.921K $350.4K $3.921K
YoY Change 0.0% 8837.16% -97.34%
Preferred Stock
YoY Change
Treasury Stock (at cost) $600.00 $600.00
YoY Change
Treasury Stock Shares
Shareholders Equity -$62.43K -$47.61K -$23.97K
YoY Change
Total Liabilities & Shareholders Equity $12.01K $12.57K $14.00
YoY Change 85671.43% 125620.0% -90.54%

Cashflow Statement

Concept 2023 Q1 2022 Q3 2022 Q1
OPERATING ACTIVITIES
Net Income -$12.40K -$4.810K -$6.626K
YoY Change 87.08% -93.18% 7.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$5.290K -$6.090K -$3.350K
YoY Change 57.91% -92.68%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.000K 5.000K 3.350K
YoY Change 79.1% -93.98%
NET CHANGE
Cash From Operating Activities -5.290K -6.090K -3.350K
Cash From Investing Activities
Cash From Financing Activities 6.000K 5.000K 3.350K
Net Change In Cash 710.0 -1.090K 0.0000000000009095
YoY Change 78065325572095900.0% 626.67%
FREE CASH FLOW
Cash From Operating Activities -$5.290K -$6.090K -$3.350K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-15112 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
10000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6626 usd
CY2022Q3 us-gaap Liabilities
Liabilities
60186 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001620749
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39210000 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
39210000 shares
CY2023Q1 pnht Treasury Stock Shares Outstanding
TreasuryStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6000000 shares
CY2022Q3 pnht Treasury Stock Shares Issued
TreasuryStockSharesIssued
0 shares
CY2022Q3 pnht Treasury Stock Shares Outstanding
TreasuryStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
50000000 usd
CY2022Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.0001
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
600 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-55569
dei Entity Registrant Name
EntityRegistrantName
PANAMERA HOLDINGS CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5707326
dei Entity Address Address Line1
EntityAddressAddressLine1
1218 Webster Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77002
dei City Area Code
CityAreaCode
713
dei Local Phone Number
LocalPhoneNumber
289-6200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33210000 shares
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3087 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
55 usd
CY2022Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
8332 usd
CY2022Q3 us-gaap Other Receivables
OtherReceivables
1098 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
12572 usd
CY2022Q3 us-gaap Assets
Assets
12572 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
17034 usd
CY2022Q3 us-gaap Related Party Deposit Liabilities
RelatedPartyDepositLiabilities
7706 usd
CY2022Q3 us-gaap Deferred Revenue And Credits
DeferredRevenueAndCredits
1500 usd
CY2023Q1 pnht Due To Related Party
DueToRelatedParty
43946 usd
CY2022Q3 pnht Due To Related Party
DueToRelatedParty
33946 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
60186 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
39210000 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
3921 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
346505 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6000000 shares
CY2023Q1 pnht Treasury Stock Shares Issued
TreasuryStockSharesIssued
0 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
600 usd
CY2022Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
0 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-398040 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-47614 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12572 usd
CY2023Q1 pnht Revenues Related Party
RevenuesRelatedParty
25000 usd
CY2022Q1 pnht Revenues Related Party
RevenuesRelatedParty
0 usd
pnht Revenues Related Party
RevenuesRelatedParty
50001 usd
pnht Revenues Related Party
RevenuesRelatedParty
0 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
25970 usd
CY2022Q1 us-gaap Cost Of Revenue
CostOfRevenue
0 usd
us-gaap Cost Of Revenue
CostOfRevenue
48864 usd
us-gaap Cost Of Revenue
CostOfRevenue
0 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
-970 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
1137 usd
us-gaap Gross Profit
GrossProfit
0 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
8167 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
5305 usd
us-gaap Professional Fees
ProfessionalFees
13219 usd
us-gaap Professional Fees
ProfessionalFees
5333 usd
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2294 usd
CY2022Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
932 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2737 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3344 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
10461 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
6237 usd
us-gaap Operating Expenses
OperatingExpenses
15956 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6237 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-14819 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8677 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
965 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
389 usd
us-gaap Interest Expense
InterestExpense
1798 usd
us-gaap Interest Expense
InterestExpense
456 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
965 usd
CY2022Q1 us-gaap Other Expenses
OtherExpenses
389 usd
us-gaap Other Expenses
OtherExpenses
1798 usd
us-gaap Other Expenses
OtherExpenses
456 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-12396 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-6626 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-16617 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-9133 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-16617 usd
us-gaap Net Income Loss
NetIncomeLoss
-9133 usd
CY2023Q1 pnht Earnings Per Share Basic And Diluted Common Stock
EarningsPerShareBasicAndDilutedCommonStock
-0.00
CY2022Q1 pnht Earnings Per Share Basic And Diluted Common Stock
EarningsPerShareBasicAndDilutedCommonStock
-0.00
pnht Earnings Per Share Basic And Diluted Common Stock
EarningsPerShareBasicAndDilutedCommonStock
-0.00
pnht Earnings Per Share Basic And Diluted Common Stock
EarningsPerShareBasicAndDilutedCommonStock
-0.00
CY2023Q1 pnht Weighted Average Number Of Basic And Diluted Shares Outstanding
WeightedAverageNumberOfBasicAndDilutedSharesOutstanding
35492609 shares
CY2022Q1 pnht Weighted Average Number Of Basic And Diluted Shares Outstanding
WeightedAverageNumberOfBasicAndDilutedSharesOutstanding
39210000 shares
pnht Weighted Average Number Of Basic And Diluted Shares Outstanding
WeightedAverageNumberOfBasicAndDilutedSharesOutstanding
37361351 shares
pnht Weighted Average Number Of Basic And Diluted Shares Outstanding
WeightedAverageNumberOfBasicAndDilutedSharesOutstanding
39210000 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-47614 usd
CY2022Q4 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
833 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-4221 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-51002 usd
CY2023Q1 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
965 usd
CY2023Q1 pnht Common Stock Surrender Held As Treasury Stock Amount
CommonStockSurrenderHeldAsTreasuryStockAmount
0 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-12396 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-62433 usd
CY2021Q4 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
67 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-2507 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-17552 usd
CY2022Q1 pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
209 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-6626 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-23969 usd
us-gaap Net Income Loss
NetIncomeLoss
-9133 usd
pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
1798 usd
pnht Imputed Interest On Related Party Loan
ImputedInterestOnRelatedPartyLoan
276 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5361 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1633 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
55 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
1098 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
0 usd
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
-1500 usd
us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
0 usd
pnht Increasedecreaseinpayroll Liabilities Related Party
IncreasedecreaseinpayrollLiabilitiesRelatedParty
394 usd
pnht Increasedecreaseinpayroll Liabilities Related Party
IncreasedecreaseinpayrollLiabilitiesRelatedParty
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9412 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7224 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7228 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7228 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
588 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
4 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3087 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3675 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
pnht Share Surrender Heled As Treasury Stock
ShareSurrenderHeledAsTreasuryStock
600 usd
pnht Share Surrender Heled As Treasury Stock
ShareSurrenderHeledAsTreasuryStock
0 usd
pnht Organization Description Of Business
OrganizationDescriptionOfBusiness
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 1 –</strong> <strong>ORGANIZATION, DESCRIPTION OF BUSINESS</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Panamera Holdings Corporation (the “Company”) is a Nevada corporation incorporated on May 20, 2014. Effective October 21, 2021, the Company changed its name from Panamera Healthcare Corporation to Panamera Holdings Corporation and increased the number of authorized common stock from 150,000,000 shares of common stock to 550,000,000 shares of common stock, par value $0.0001 per share. The Company’s fiscal year end is July 31.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company intended to offer management and consulting services to healthcare organizations but have redirected our efforts now to pursuing business opportunities including but not limited to the environmental services industry, emerging innovative technologies and individual health choices led by innovation with integration. To date, the Company’s activities have been limited to its formation and the raising of equity capital and consulting services related to an agreement effective on March 1, 2022 with First DP Ventures, LP dba First Primary Care of Houston, Texas.</p>
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p>
pnht Fixed Monthly Payment
FixedMonthlyPayment
8333 usd
CY2023Q1 us-gaap Customer Deposits Current
CustomerDepositsCurrent
0 usd
CY2022Q3 us-gaap Customer Deposits Current
CustomerDepositsCurrent
1500 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-414657 usd
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
50001 usd
CY2023Q1 pnht Accrued Interest Current
AccruedInterestCurrent
43946 usd
CY2021Q3 pnht Accrued Interest Current
AccruedInterestCurrent
33946 usd
us-gaap Insurance Services Revenue
InsuranceServicesRevenue
1798 usd
pnht Prepaid Wages Related Party
PrepaidWagesRelatedParty
0 usd
CY2022 pnht Prepaid Wages Related Party
PrepaidWagesRelatedParty
1098 usd
CY2023Q1 us-gaap Preferred Stock Discount On Shares
PreferredStockDiscountOnShares
50000000 usd
CY2023Q1 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0.0001
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 pnht Voluntarily Surrendered Shares
VoluntarilySurrenderedShares
6000000 shares
CY2023Q1 pnht Common Stock Shares Issued One
CommonStockSharesIssuedOne
39210000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3321000 shares
CY2022Q3 pnht Common Stock Shares Issued One
CommonStockSharesIssuedOne
39210000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6000000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
600 usd
pnht Fixed Monthly Payment
FixedMonthlyPayment
8333 usd
CY2023Q1 pnht Accounts Receivable Related Parties Diverted Amount
AccountsReceivableRelatedPartiesDivertedAmount
8333 usd

Files In Submission

Name View Source Status
0001640334-23-000397-index-headers.html Edgar Link pending
0001640334-23-000397-index.html Edgar Link pending
0001640334-23-000397.txt Edgar Link pending
0001640334-23-000397-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pnht-20230131.xsd Edgar Link pending
pnht-20230131_cal.xml Edgar Link unprocessable
pnht-20230131_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pnht_10q.htm Edgar Link pending
pnht_ex311.htm Edgar Link pending
pnht_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
pnht-20230131_lab.xml Edgar Link unprocessable
pnht-20230131_pre.xml Edgar Link unprocessable
pnht_10q_htm.xml Edgar Link completed